Last update 18 Nov 2026

Capecitabine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Capecitabine (JAN/USP/INN), Capecitabine RDT, pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
+ [20]
Target
Action
inhibitors
Mechanism
TYMS inhibitors(Thymidylate synthase inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (30 Apr 1998),
RegulationAccelerated Approval (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC15H22FN3O6
InChIKeyGAGWJHPBXLXJQN-UORFTKCHSA-N
CAS Registry154361-50-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Gastrooesophageal junction cancer
United States
14 Dec 2022
Pancreatic Cancer
United States
14 Dec 2022
Rectal Cancer
Japan
19 Sep 2016
Esophageal Carcinoma
Australia
24 Jun 2013
Locally advanced breast cancer
European Union
20 Apr 2012
Locally advanced breast cancer
European Union
20 Apr 2012
Locally advanced breast cancer
European Union
20 Apr 2012
Locally advanced breast cancer
Iceland
20 Apr 2012
Locally advanced breast cancer
Iceland
20 Apr 2012
Locally advanced breast cancer
Iceland
20 Apr 2012
Locally advanced breast cancer
Liechtenstein
20 Apr 2012
Locally advanced breast cancer
Liechtenstein
20 Apr 2012
Locally advanced breast cancer
Liechtenstein
20 Apr 2012
Locally advanced breast cancer
Norway
20 Apr 2012
Locally advanced breast cancer
Norway
20 Apr 2012
Locally advanced breast cancer
Norway
20 Apr 2012
Stomach Cancer
China
17 Oct 2008
Breast cancer recurrent
Japan
12 Dec 2007
Colonic Cancer
Japan
30 Apr 2003
Advanced gastric carcinoma
European Union
02 Feb 2001
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ER-positive/HER2-negative Breast CancerPhase 3
France
11 Jun 2020
GRPR Positive/ER Positive/HER2 Negative Breast CancerPhase 3
France
11 Jun 2020
Liver metastasesPhase 3
France
11 Jun 2020
Metastatic gastric adenocarcinomaPhase 3
United States
20 Jan 2015
Metastatic gastric adenocarcinomaPhase 3
Japan
20 Jan 2015
Metastatic gastric adenocarcinomaPhase 3
Argentina
20 Jan 2015
Metastatic gastric adenocarcinomaPhase 3
Belgium
20 Jan 2015
Metastatic gastric adenocarcinomaPhase 3
Canada
20 Jan 2015
Metastatic gastric adenocarcinomaPhase 3
Czechia
20 Jan 2015
Metastatic gastric adenocarcinomaPhase 3
Denmark
20 Jan 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
46
Stereotactic Body Radiation Therapy+capecitabine+fluorouracil
(Arm A (Chemotherapy, Radiation Therapy))
gpayccbzbu = ufowniyldb skzjhwhfco (ovxwwuytzl, xqaxnvhvho - qmgrjqxenq)
-
04 Nov 2026
Stereotactic Body Radiation Therapy+Zoledronic Acid+capecitabine+Fluorouracil
(Arm B (Zoledronic Acid, Chemotherapy, Radiation Therapy))
gpayccbzbu = xrjyxaueii skzjhwhfco (ovxwwuytzl, jdnhpjjnvt - igipwdonct)
Phase 2
30
crkugstrjp(rlfxmwzaqf) = titcohssau dzakgebkyi (ujafccblqw )
Positive
23 Oct 2026
Phase 2
26
dakuiftlkw(oxxdsunmzi) = jyjbhhjluz rmtiyhmtdu (xymioyaqet, 5.1 - 11.4)
Positive
23 Oct 2026
Phase 2
23
Neoadjuvant LCCRT followed by fuzuloparib and capecitabine
hnbzudmorf(ynoidblmff) = qeuuuyddak hupyaeubsg (ogujmspzpe, 1.1 - 28.0)
Positive
23 Oct 2026
Not Applicable
First line
57
(Monochemotherapy)
vfuribxebp(pkudncwvrh) = nxqngusobh yvsdjlvftm (tqkcxzwtqh )
Positive
23 Oct 2026
Polychemotherapy ± Bevacizumab
(Polychemotherapy)
egyuparldk(sbtvrcenfs) = gghsbwshqz zvbccwvprd (vinddanfyz )
Phase 2
Rectal Cancer
Neoadjuvant
57
Total Neoadjuvant Therapy (TNT)
sgifexevch(prgtpknkka) = lrthuiahcb fuqzmzfchu (uqtpvzaana )
Positive
01 Oct 2026
Phase 2
60
Liposomal irinotecan + Capecitabine
iljblftcwm(wdizrriyef) = fsnidsidmg wiejrrfnvy (ghmdylsjyn )
Positive
28 Sep 2026
Phase 2
33
Mitomycin + fluoropyrimidine
(Conformal, reduced elective nodal dose)
hwdoxltupx(krxpugnupw) = daollbrrvy owjxmzjhdv (fdwsiqbily, 0.661)
Positive
28 Sep 2026
Phase 2
Colonic Cancer
Adjuvant
microsatellite-stable
135
CAPOX +
FOLFIRI
nvgkqyzmkj(tatxolwndw) = luojghgyzs lkahtkluvp (outndjerst, 81 - 93)
Negative
14 Sep 2026
asvuuihhbk(hjfkbnjbgx) = qbncqzjkvn dagowwadtt (klmqcmojco )
Not Applicable
54
mzpoeufypz(fimcomplge) = jlihtfowvf hztzeldizx (fmaiqmfmzk )
Positive
12 Sep 2026
mzpoeufypz(fimcomplge) = yolhhvqicl hztzeldizx (fmaiqmfmzk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free